| Previous Close | 0.844 |
| Open | 0.850 |
| Bid | 0.000 x 0 |
| Ask | 0.000 x 0 |
| Day's Range | 0.780 - 0.868 |
| 52 Week Range | 0.450 - 2.650 |
| Volume | 77,009 |
| Avg. Volume | 77,947 |
| Market Cap | 18.6M |
| Beta | 0.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.015 |
| Earnings Date | Nov 8, 2018 - Nov 12, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Mentor Capital, Inc. (MNTR) announced that its investment in G FarmaLabs Limited has increased to $2,700,000 following yesterday’s seventh investment tranche delivered to G Farma of $250,000 from Mentor for additional leased equipment and working capital. In addition to receiving consulting fees, repayment, interest, and lease payments, Mentor has captured a $1 option for a 3.75% equity interest in the G Farma Family of Businesses. Nicole Gonzalez, Founder of G FarmaBrands, comments, “With financial backing from Mentor Capital, G FarmaLabs has hit its benchmarks on the way to building cannabis efficient facilities and production lines.” Ata Gonzalez, Co-Founder of G FarmaLabs concludes, “Chet provides both money and a wealth of knowledge.
Mentor Capital, Inc. (MNTR) announced that its investment in G FarmaLabs Limited has increased to $2,700,000 following yesterday’s seventh investment tranche delivered to G Farma of $250,000 from Mentor for additional leased equipment and working capital. Nicole Gonzalez, Founder of G FarmaBrands, comments, “With financial backing from Mentor Capital, G FarmaLabs has hit its benchmarks on the way to building cannabis efficient facilities and production lines.” Ata Gonzalez, Co-Founder of G FarmaLabs concludes, “Chet provides both money and a wealth of knowledge. “Mentor Capital focuses new investment from shareholders and other investors on larger cannabis companies, like G Farma, that have the potential to go public and who may be incubated by Mentor along that path,” explained Mentor Capital, Inc. CEO, Chet Billingsley.
Everett Jolly indicated that today’s guest hasn’t been on the show for a couple of years, but that he’s super excited to have them back. For 32 years, the Company has been providing advice and financing for companies, starting in Silicon Valley, then to San Diego into the biotech sector in particular for cancer. Then the Company shifted to a cancer-focused medical marijuana investment, which brought them into the cannabis sector.
SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Mentor Capital, Inc. (MNTR) announced that it had filed its quarterly 10-Q filing for the second quarter ended June 30, 2018, with the Securities and Exchange Commission. For the quarter ended June 30, 2018, Mentor had revenues of $1,231,260 and gross profit of $378,564 with a resulting net loss attributable to Mentor of ($74,606) or (0.3 cents) per share. This is an improvement in revenue from the prior year quarter ended June 30, 2017 revenues of $764,549 and gross profit of $268,664, with a resulting net loss attributable to Mentor of ($258,246) of (1.1 cents) per share.
SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Mentor Capital, Inc. (MNTR), an M&A and funding provider for the cannabis and medical marijuana sector, will start to trade on the OTCQX Best Market effective today. Mentor joins more than twenty companies during 2018 that have upgraded to OTCQX from the OTCQB® Venture Market, according to OTC Markets Group, Inc. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com as well as other popular financial websites. OTCQX is designed for established, investor-focused U.S. and international companies that have met high financial standards, are current in their financial reporting and have been sponsored by a professional third-party advisor.
Mentor Capital, Inc. (MNTR), an M&A and funding provider for the cannabis and medical marijuana sector, will start to trade on the OTCQX Best Market effective today. Mentor joins more than twenty companies during 2018 that have upgraded to OTCQX from the OTCQB® Venture Market, according to OTC Markets Group, Inc. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com as well as other popular financial websites. OTCQX is designed for established, investor-focused U.S. and international companies that have met high financial standards, are current in their financial reporting and have been sponsored by a professional third-party advisor.
NEW YORK , Aug. 6, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Mentor Capital, Inc. (OTCQX: MNTR), ...
Mentor Capital, Inc. (MNTR) announced that it has filed its quarterly 10-Q filing for the first quarter ended March 31, 2018, with the Securities and Exchange Commission. This is an improvement in revenue from the prior year quarter ended March 31, 2017 revenues of $738,144 and gross profit of $263,896. The net loss attributable to Mentor for the prior year quarter ended March 31, 2017, was ($460,176) or (0.21 cents) per share.
Mentor Capital, Inc. announced that it has filed its annual 10-K filing for the year ended December 31, 2017 with the SEC.
Mentor Capital, Inc. announced that it has extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Cannabis veteran and Pueblo founder, Pat Leonard, comments, "Chet Billingsley and I first discussed working together back in 2013.
Mentor Capital, Inc. announced that during January it has funded an additional $900,000 into G FarmaLabs bringing the ten month multi-investment total by Mentor into G Farma to $1.8 million, which is in addition to an early and separate $600,000 stock transaction.
Mentor Capital, Inc. announced in a year-end note to shareholders that the corporation looks to immediately receive $2 million, successfully concluding its three-year litigation with Bhang Corporation.
Mentor Capital, Inc. announced that it has filed its quarterly 10-Q filing for the third quarter ended September 30, 2017 with the Securities and Exchange Commission.